Makarla S, Bavle R, Topajiche S
J Oral Maxillofac Pathol. 2025; 28(4):602-611.
PMID: 39949704
PMC: 11819642.
DOI: 10.4103/jomfp.jomfp_292_24.
Daloiso A, Franz L, Mondello T, Tisato M, Negrisolo M, Zanatta P
Cancers (Basel). 2024; 16(22).
PMID: 39594842
PMC: 11592668.
DOI: 10.3390/cancers16223887.
Belfiore M, Nardone V, DOnofrio I, Pirozzi M, Sandomenico F, Farese S
Biomedicines. 2024; 12(9).
PMID: 39335592
PMC: 11428618.
DOI: 10.3390/biomedicines12092080.
Shofoluwe N, Aliyu H, Kabir B, Mohammed I, Hamza M, Abdullahi A
J West Afr Coll Surg. 2024; 14(4):417-420.
PMID: 39309385
PMC: 11412586.
DOI: 10.4103/jwas.jwas_141_23.
Liao T, Chen Y, Li Z, Hsiao A, Huang Y, Hao R
Cancer Immunol Res. 2024; 12(10):1468-1484.
PMID: 38920249
PMC: 11443317.
DOI: 10.1158/2326-6066.CIR-23-0622.
Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer.
Brennan K, Espin-Perez A, Chang S, Bedi N, Saumyaa S, Shin J
Genome Med. 2023; 15(1):98.
PMID: 37978395
PMC: 10656821.
DOI: 10.1186/s13073-023-01236-w.
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.
Koukourakis M, Xanthopoulou E, Koukourakis I, Fortis S, Kesesidis N, Karakasiliotis I
Cancer Diagn Progn. 2023; 3(5):551-557.
PMID: 37671311
PMC: 10475926.
DOI: 10.21873/cdp.10254.
Long-Term Care and Follow-Up in Laryngeal Cancer Patients: A Multicenter Retrospective Analysis.
Marijic B, Tudor F, Janik S, Grasl S, Frommlet F, Marzic D
J Pers Med. 2023; 13(6).
PMID: 37373916
PMC: 10302671.
DOI: 10.3390/jpm13060927.
Squamous Cell Carcinoma of Duodenum Secondary to Metastasis From Recurrent Head and Neck Cancer: A Case Report and Literature Review.
Zaw S, Zaw T, Chen R, El-Far A
Cureus. 2023; 15(5):e38898.
PMID: 37313071
PMC: 10259689.
DOI: 10.7759/cureus.38898.
Association between radiotherapy for surgically treated oral cavity cancer and secondary lung cancer.
He D, Zhang J, Xiang Y, Wu P, Li G, Chang H
Front Public Health. 2023; 11:1120671.
PMID: 37033050
PMC: 10073750.
DOI: 10.3389/fpubh.2023.1120671.
Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck Cancer.
Chung C, Lin C, Chen C, Hsueh C, Chang Y, Wang C
Adv Sci (Weinh). 2023; 10(15):e2204514.
PMID: 37026630
PMC: 10214241.
DOI: 10.1002/advs.202204514.
To CT or not to CT: Questioning the Cost-Effectiveness of CT Thorax in Head and Neck Cancers.
Usman N, Shetty P, Dikhit P, Dinker D, Kumar N, Palod A
Indian J Surg Oncol. 2023; 14(1):28-33.
PMID: 36891447
PMC: 9986160.
DOI: 10.1007/s13193-022-01608-5.
Abdominal ultrasound in head and neck squamous cell carcinoma staging: yes or no?.
Hoing B, Wittig L, Weber L, Stuck B, Mattheis S, Hussain T
Eur Arch Otorhinolaryngol. 2022; 280(4):1885-1891.
PMID: 36357610
DOI: 10.1007/s00405-022-07723-x.
Adenosquamous Carcinoma with the Acantholytic Feature in the Oral Cavity: A Case Report and Comprehensive Literature Review.
Abe T, Yamazaki M, Maruyama S, Ikeda N, Sumita Y, Tomihara K
Diagnostics (Basel). 2022; 12(10).
PMID: 36292088
PMC: 9600722.
DOI: 10.3390/diagnostics12102398.
A nomogram for prediction of distant metastasis in patients with hypopharyngeal squamous cell carcinoma: a study based on the SEER database.
Liu X, Wang S, Wu W, Zhang J, Peng S
Am J Transl Res. 2022; 14(8):5409-5419.
PMID: 36105011
PMC: 9452331.
Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
Zhu X, Zhou J, Zhou L, Zhang M, Gao C, Tao L
J Transl Med. 2022; 20(1):405.
PMID: 36064552
PMC: 9446763.
DOI: 10.1186/s12967-022-03544-y.
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma.
Islam S, Qassem K, Islam S, Parag R, Rahman M, Farhat W
Cell Death Dis. 2022; 13(8):696.
PMID: 35945195
PMC: 9363464.
DOI: 10.1038/s41419-022-05126-8.
Pericardial Metastasis From Recurrent Squamous Cell Carcinoma of Hypopharynx in a Living Patient.
Antala D, Mohamed K, Kim L, Bhatti S, Adhikari P, Oliff I
Cureus. 2022; 14(4):e24216.
PMID: 35602822
PMC: 9113610.
DOI: 10.7759/cureus.24216.
Crumbs3 is expressed in oral squamous cell carcinomas and promotes cell migration and proliferation by affecting RhoA activity.
Yokoyama Y, Iioka H, Horii A, Kondo E
Oncol Lett. 2022; 23(6):173.
PMID: 35497937
PMC: 9019858.
DOI: 10.3892/ol.2022.13293.
Loss of CDH1 promotes the metastasis of hypopharyngeal squamous cell carcinoma through the STAT3-MMP-9 signaling pathway.
Mu L, Liu X, Liu X, Sa N, Zhou S, Lv Z
Transl Cancer Res. 2022; 8(4):1476-1485.
PMID: 35116890
PMC: 8799152.
DOI: 10.21037/tcr.2019.07.51.